AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,791 | -1.3% | 1,795 | -8.9% | 0.06% | 0.0% |
| Q2 2023 | $92,026 | +5.1% | 1,971 | -13.9% | 0.06% | +14.6% |
| Q1 2023 | $87,577 | -49.5% | 2,289 | -27.7% | 0.05% | -47.3% |
| Q4 2022 | $173,387 | -60.8% | 3,164 | -75.6% | 0.09% | -48.3% |
| Q3 2022 | $442,000 | +262.3% | 12,981 | +0.8% | 0.18% | +291.1% |
| Q2 2022 | $122,000 | +9.9% | 12,882 | +65.1% | 0.04% | -10.0% |
| Q1 2022 | $111,000 | -36.6% | 7,802 | -5.6% | 0.05% | -24.2% |
| Q4 2021 | $175,000 | +9.4% | 8,266 | +15.7% | 0.07% | -5.7% |
| Q3 2021 | $160,000 | -14.4% | 7,146 | -5.0% | 0.07% | -9.1% |
| Q2 2021 | $187,000 | -38.3% | 7,526 | -28.0% | 0.08% | -39.8% |
| Q1 2021 | $303,000 | +14.3% | 10,454 | +1.7% | 0.13% | +16.4% |
| Q4 2020 | $265,000 | -32.2% | 10,276 | -19.0% | 0.11% | -46.3% |
| Q3 2020 | $391,000 | +8.9% | 12,686 | -12.1% | 0.20% | +20.6% |
| Q2 2020 | $359,000 | -0.8% | 14,425 | -15.4% | 0.17% | +14.1% |
| Q1 2020 | $362,000 | -16.4% | 17,057 | -12.7% | 0.15% | +109.9% |
| Q4 2019 | $433,000 | – | 19,531 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |